@megkesh profile picture
Meghana Keshavan @megkesh

biotech nerd, biotech writer @statnews

Joined March 2013
  • Tweets 5,281
  • Following 1,045
  • Followers 7,350
243 Photos and videos
Is this real?
U.S. FDA
@US_FDA
Mar 14
The FDA is moving at LIGHT SPEED ⚡️🇺🇸 ✅ Cutting red tape on BIOSIMILARS to lower costs for your family ✅ MAHA Mission for supplement safety ✅ STOPPING the Screwworm parasite ✅ 1K NEW JOBS for top scientists ✅ Launching AEMS to modernize safety and save taxpayer dollars
1:46
586
Meghana Keshavan retweeted
Deepa Seetharaman
@dseetharaman
Feb 25
Dance like no one’s watching. Write like your fact-checking email will wind up an exhibit in the Musk v Altman trial. storage.courtlistener.com/re…

Exhibit 4 – #403, Att. #4 in Musk v. Altman (N.D. Cal., 4:24-cv-04722) – CourtListener.com

MOTION in Limine No. 2 filed by Elon Musk. Responses due by 2/25/2026. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Molo, Steven) (Filed on 2/24/2026)...

courtlistener.com
3
8
59
11,423
Meghana Keshavan retweeted
Matthew Herper
@matthewherper
Feb 10
FDA refuses to review Moderna’s influenza vaccine statnews.com/2026/02/10/fda-… The quotes here are... quite a thing. Vinay Prasad: "Your control arm does not reflect the best-available standard of care in the United States at the time of the study.” Moderna: FDA previously said control arm was "acceptable." Stephane Bancel: the decision the decision “does not further our shared goal of enhancing America’s leadership in developing innovative medicines." $MRNA and also $PFE

FDA refuses to review Moderna’s influenza vaccine

FDA refuses to review Moderna’s influenza vaccine, which could raise concerns about the agency’s posture toward vaccines and drug approvals more generally.

statnews.com
40
94
238
64,438
Meghana Keshavan retweeted
STAT
@statnews
Jan 14
Will AI replace doctors? At our STAT@JPM event, Robert Nelsen told the audience, "Yes." #JPM26
1:02
47
85
257
80,595
In which I discuss how weird I’ve gotten with AI m.youtube.com/watch?fbclid=I…

2025 SODP Symposium | Meghana Keshavan - What Journalists Saw First:...

In this session, STAT News journalist Meghana Keshavan, BS discusse...

youtube.com
1
2
402
Meghana Keshavan retweeted
JMIR Publications
@jmirpub
8 Dec 2025
The 2025 SODP Symposium on #DigitalMentalHealth & #AI is just a few days away on Dec 12, 1-3:30 PM ET! Don't miss this FREE virtual event featuring: S. Choudhary (@mindmanure), @megkesh, K. Myrick, B. Nelson, @SteveSiddals, & Dr. Rahmani. Register now: bit.ly/4oADJas
1
3
245
Hashtag longevity. statnews.com/2025/11/12/abbv…

AbbVie cuts ties with Google-backed longevity company, lays off scientists

AbbVie is ending a decade-long partnership with Calico Life Sciences, an Alphabet-funded biotech company focused on aging research, and laying off scientists.

statnews.com
338
“Nearly 30 years after the sequencing of the human genome, bespoke therapies are close to reality,” Makary and Prasad wrote. statnews.com/2025/11/12/fda-…

FDA chiefs offer roadmap to expand custom gene-editing treatments like Baby KJ's

Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to treat Baby KJ's ultra-rare disease.

statnews.com
325
Meghana Keshavan retweeted
Jason Ukman
@JasonUkman
4 Nov 2025
“We are witnessing nothing less than a clown show at FDA right now.”
Matthew Herper
@matthewherper
4 Nov 2025
Experts worry FDA’s credibility is being shredded by scandal and ‘soap opera’ In recent months, the agency has been beset by dismissals, policy reversals, and controversies statnews.com/2025/11/04/fda-…
2
5
19
6,152
Meghana Keshavan retweeted
STAT
@statnews
2 Nov 2025
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory authority, STAT has learned. trib.al/RRsqQwS

FDA’s top drug regulator resigns amid investigation

George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory authority, STAT has learned.

statnews.com
6
4
3,868
Oh well this is interesting statnews.com/2025/08/09/vina…

Vinay Prasad returns to the FDA, weeks after his ouster

HFO HFO Vinay Prasad returns to a top FDA role just weeks after his abrupt dismissal.

statnews.com
4
558
Meghana Keshavan retweeted
josh hardman@Josh__Hardman
29 Jul 2025
Psychedelics have promise. But after losing my son, we can't ignore the dangers. Thoughtful Opinion piece by Kristin Nash, who is doing great work. eu.usatoday.com/story/opinio…

Psychedelics have promise. But after losing my son, we can't ignore the dangers. | Opinion

RFK Jr. wants public access to psychedelics, which have promise to help those with PTSD, addiction and other conditions. But there are real risks.

usatoday.com
12
5
42
4,620
Meghana Keshavan retweeted
STAT
@statnews
30 Jul 2025
#Breaking: Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial decisions about a treatment for boys with Duchenne muscular dystrophy. trib.al/vfYBVjn

Vinay Prasad, a powerful FDA official, departs after controversy over rare disease drug

Vinay Prasad, a top FDA official, is out after less than three months on the job.

statnews.com
55
132
458
458,834
Meghana Keshavan retweeted
Jonathan Wosen, Ph.D.@JonathanWosen
25 Jul 2025
The FDA and NIH are moving away from animal testing, but do researchers think that's a good idea? @AAASMassMedia Fellow @marissarussoo and I spoke with 10 researchers across academia and biotech to find out. Story via @statnews. statnews.com/2025/07/25/nih-…

NIH, FDA plan to reduce animal testing draws mixed reactions among scientists

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

statnews.com
1
6
9
2,920
Meghana Keshavan retweeted
Jason Mast@Jasonmmast
16 Jul 2025
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move, terminates work on other gene therapies We'll be doing a bit more reporting on this. I'm reachable at Jason.Mast@statnews.com and JasonMast.05 on Signal statnews.com/2025/07/16/sare…

Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move

Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following the deaths of two teenagers administered its gene therapy for Duchenne...

statnews.com
3
3
11
3,491
Eesh.
Jiankui He@Jiankui_He
1 Jul 2025
I will destroy the pharmaceutical industry.
494
Meghana Keshavan retweeted
STAT
@statnews
1 Jul 2025
U.S. judge says HHS layoffs were likely unlawful and must be halted - via @AP trib.al/4xp9Q6P

U.S. judge says HHS layoffs were likely unlawful and must be halted

A federal judge has ruled that the recent mass layoffs at HHS were likely unlawful and ordered the Trump administration to halt plans to downsize and reorganize the nation's health workforce.

statnews.com
6
5
3,006
Meghana Keshavan retweeted
Atul Gawande
@Atul_Gawande
1 Jul 2025
STAGGERING: This new study of 133 countries is the first to estimate the impact of all USAID’s work. In 2 decades, it saved *92M* lives. Current cuts, if not reversed, are forecast to cost *14M* lives thru 2030. thelancet.com/journals/lance…
906
2,818
6,126
1,368,150
Meghana Keshavan retweeted
Psychedelic Alpha
@Psyched_Alpha
1 Jul 2025
BREAKING: Beckley's 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study Read our analysis of the largest study of 5-MeO-DMT: psychedelicalpha.com/news/be…
3
20
58
5,340
Meghana Keshavan retweeted
Adam Feuerstein ✡️
@adamfeuerstein
1 Jul 2025
Psychedelic therapy from $ATAI and Beckley Psytech shows promise in mid-stage study in treatment-resistant depression statnews.com/2025/07/01/psyc… via @megkesh

Psychedelic therapy shows promise in mid-stage study in treatment-resistant depression

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of treatment-resistant depression in a mid-stage trial.

statnews.com
14
9
49
15,620
Load more